Cargando…
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Antibodies and Fc-fusion antibody-like proteins have become successful biologics developed for cancer treatment, passive immunity against infection, addiction, and autoimmune diseases. In general these biopharmaceuticals can be used for blocking protein:protein interactions, crosslinking host recept...
Autor principal: | Saunders, Kevin O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568213/ https://www.ncbi.nlm.nih.gov/pubmed/31231397 http://dx.doi.org/10.3389/fimmu.2019.01296 |
Ejemplares similares
-
Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
por: Saxena, Abhishek, et al.
Publicado: (2016) -
Editorial: Effector functions of therapeutic antibodies
por: Boross, Peter, et al.
Publicado: (2023) -
Metabolic Modulation in Macrophage Effector Function
por: Diskin, Ciana, et al.
Publicado: (2018) -
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
por: Thran, Moritz, et al.
Publicado: (2023) -
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
por: Golay, Josée, et al.
Publicado: (2022)